Vaccine development is proceeding at record speed, with one candidate announcing early results from a U.S. phase 3 trial this week and likely more to come. If all goes well, the first doses of a coronavirus vaccine might become available in early 2021. But with this rushed timeline, how do we know it’s safe?
